Diphenhydramine Hydrochloride Tablet, Film Coated
NDC 71679-311
Product Information
Diphenhydramine Hydrochloride is a OTC MONOGRAPH DRUG-approved product labeled by Health Pharma Usa Llc. This medication is typically used as a histamine h1 receptor antagonists [moa]. It is supplied as a blue tablet, film coated for oral administration. This product entry covers the primary NDC 71679-311 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Product Characteristics
S25
Code Structure Chart
Product Details
What is NDC 71679-311?
What are the uses of this product?
What are Active Ingredients of this product?
- DIPHENHYDRAMINE HYDROCHLORIDE 25 mg/1 - A histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a hypnotic, an antiparkinson, and as an ingredient in common cold preparations. It has some undesired antimuscarinic and sedative effects.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- DIPHENHYDRAMINE HYDROCHLORIDE (UNII: TC2D6JAD40)
- DIPHENHYDRAMINE (UNII: 8GTS82S83M) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
- CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)
- ANHYDROUS DIBASIC CALCIUM PHOSPHATE (UNII: L11K75P92J)
- MAGNESIUM STEARATE (UNII: 70097M6I30)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- TITANIUM DIOXIDE (UNII: 15FIX9V2JP)
- FD&C BLUE NO. 1 (UNII: H3R47K3TBD)
- FD&C BLUE NO. 2 (UNII: L06K8R7DQK)
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.